Search Results 701-710 of 19288 for hemoglobin

1. A Study Of Ex Vivo Expansion (ACT-X) - Mayo Clinic

   The following laboratory values obtained ≤ 28 days prior to registration. Hemoglobin ≥910.0 g/dl. Absolute neutrophil count (ANC) ≥1500/mm3. Platelet count ...

2. Investigational Trial To Evaluate XC001 Delivered Via An Cardiac Catheter In Subjects With Chronic Angina. - Mayo Clinic

   Body mass index \> 45 kg/m2. 5. Hemoglobin \< 10 g/dL, absolute neutrophil count \< 1.2 × 103 per µL, platelet count \< 75,000 per µL, alanine ...

3. A Study of the Effectiveness of Sulfasalazine in Preventing Acute Diarrhea in Patients with Cancer who are Undergoing Pelvic Radiation Therapy - Mayo Clinic

   Life expectancy ≥ 6 months; Hemoglobin ≥ 10.0 g/dL; Leukocytes ≥ 3,500/mm^3; ANC ≥ 1,500/mm^3; Platelet count ≥ 100,000/mm^3; Creatinine ≤ 1.5 times upper ...

4. Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

   Hemoglobin > 8.0 gm/dL; Total bilirubin within normal limits. Ejection fraction by MUGA scan or echocardiogram ≥ lower limit of institutional normal ...

5. A Trial of RAdium-223 and SABR Versus SABR for oligomEtastatic Prostate caNcerS (RAVENS) - Mayo Clinic

   Hemoglobin ≥ 10 g/dL. Patient must have the ability to understand and the willingness to sign a written informed consent document. Exclusion Criteria.

6. A Study to Evaluate Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration In HPV Head And Neck Cancer - Mayo Clinic

   Hemoglobin ≥8.0g/dL;; Creatinine ≤ 1.5 mg/dL or creatinine clearance ≥ 50 mL/min;; Total or direct bilirubin < 2 x institutional upper limit of normal (ULN); ...

7. Study of Canakinumab in Patients With Myelofibrosis - Mayo Clinic

   - Hemoglobin < 10 g/dL; - Transfusion-dependency (at least 6 units of packed red blood cells (PRBC) in the 12 weeks prior to study enrollment, for a ...

8. A Study of Minimally Invasive Pericardiotomy as a New Treatment for Heart Failure - Mayo Clinic

   Any hemoglobin (Hgb) < 8.0 g/dl within 30 days prior to randomization. Any GFR < 20 ml/min/1.73 m2 within 30 days prior to randomization. Significant ...

9. Radiation Therapy With or Without Bicalutamide in Treating Patients With Stage II, Stage III, or Recurrent Prostate Cancer - Mayo Clinic

   Hemoglobin at least 10 g/dL. Hepatic: Bilirubin normal; Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) no greater than 2.5 times normal.

10. A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Disease (PF-ILDs) - Mayo Clinic

    DLCO ≥ 25% of predicted normal corrected for hemoglobin (Hb) at Visit 1. 7. Women of childbearing potential (WOCBP) must be ready and able to use highly ...